End the transgender 'unregulated live experiment on children' say whistleblowing workers who have quit clinic treating patients as young as THREE
Five whistleblowing workers at the only NHS transgender clinic in Britain have quit over fears children as young as three are going through unnecessary gender reassignment treatment.
The clinicians from the Gender Identity Development Service (GIDS) clinic based in London and Leeds left over concerns children were being incorrectly diagnosed with gender dysphoria.
It was feared some gay children struggling with their sexual identity are being incorrectly diagnosed as transgender.
Specialists also worried that some of the youngsters were being referred and pressured into having gender change treatment after suffering homophobic bullying.
All five former staff members were part of the team deciding if youngsters should be given hormone blockers to stop their development before puberty, according to the Times.
The patients then take a course of cross-sex hormones at the age of 16 depending on whether they want to develop as male or female.
At least 18 staff have reportedly quit the controversial clinic over the past three years, citing fears not enough checks are being done to correctly diagnose child patients.
One of the five whistleblowers even said the only reason many stayed in their post was to prevent more children from having the treatment.
Referrals to the clinic risen in recent years, with 94 in 2010, rising to 2,519 by last year, with the youngest patient aged just three.
One of the clinicians told The Times: 'I felt for the last two years what kept me in the job was the sense there was a huge number of children in danger.
'I was there to protect children from being damaged.'
Experts fear the treatments are being given without exploring the underlying reason for the children's confusion over their sexuality.
An Oxford professor said the treatments were 'unregulated live experiments on children' with some diagnosis not supported by any evidence.
Carl Heneghan, director of the Centre of Evidence-based Medicine at Oxford University, told The Times: 'Given paucity of evidence, the off-label use of drugs [for outcomes not covered by the medicine's licence] in gender dysphoria treatment largely means an unregulated live experiment on children.'
GIDS, which is part of the Tavistock and Portman NHS Foundation Trust, denied these claims and insisted careful diagnoses were made in these complex cases.
A spokesman told the Times: 'It is only in recent years that the number of young people attending specialist services worldwide has dramatically increased.
'Prior to this the numbers have been small and it has therefore been difficult to collect sufficient evidence to fully evaluate treatment pathways.
archive.fo
dailymail.co.uk
